LT antagonists are used in asthma for ?
Ans. is 'c' i.e., Prophylactic therapy for mild to moderate asthma Monteleukast and zafirleucast are cystenyl LT1 (cys LT1) receptor antagonists. They are indicated for prophylactic therapy of mild to moderate asthma as alternatives to inhaled glucocoicoids.
Along with beta agonists to reduce steroids
In place of beta blockers as sole therapy
Prophylactic therapy for mild to moderate asthma
Definitive therapy in acute attack of asthma